期刊文献+

术后早期肠外联合肠内营养对老年进展期胃癌患者预后效果分析 被引量:5

Effect of Early Parenteral Nutrition Combined with Enteral Nutrition Support on the Prognosis of Advanced Gastric Cancer in Elderly Patients
原文传递
导出
摘要 目的:探讨术后早期肠外联合肠内营养对老年进展期胃癌临床早期预后的影响。方法:选择106例老年进展期胃癌患者,随机分为观察组56例和对照组50例,术后分别给予肠外联合肠内营养和肠外营养支持,观察2组患者术前术后C反应蛋白、血清清蛋白(ALB)、前白蛋白和血红蛋白(Hb)、肛门排气时间、并发症、住院时间及疲劳指数。结果:观察组在术后CRP水平下降优于对照组(P<0.05),观察组肛门排气时间、并发症、住院时间及疲劳指数均优于对照组(P<0.05),但术后血清清蛋白(ALB)、前白蛋白和血红蛋白(Hb)比较无明显差异。结论:术后早期肠外联合肠内营养减轻老年进展期胃癌患者术后的应激反应,减少并发症,促进恢复,改善早期预后。 Objective: To investigate the effects of early parenteral nutrition combined with enteral nutrition on the early clinical prognosis of advanced gastric cancer in old patients. Methods: A total of 106 cases of old patients with advanced gastric cancer were randomly divided into the observation group( 56 cases) and control group (50 cases). After operation, patients in observation group were given parenteral nutrition combined with enteral nutrition, and patients in control group were given only parenteral nutrition. The serum CRP levels, serum aibumin(ALB), serum prealbumin, Hemoglobin(Hb), flatus time, complications, hospital stays and fatigue index were measured before and after operation. Results: Compared with the control group, the serum CRP levels after operation was significantly lower in observation group (P〈0.05). The indicators like flatus time, complication, hospital stays and fatigue index in observation group had better results than in the control group (P〈0.05), but the serum aibumin(ALB), serum prealbumin, Hemoglobin(Hb) had no obvious differences. Conclusion: The early parenteral nutrition combined with enteral nutrition can reduce the trauma stress and complications of advanced gastric cancer in old patients, promote recovery, and improve the early prognosis.
出处 《现代生物医学进展》 CAS 2015年第34期6678-6681,共4页 Progress in Modern Biomedicine
基金 上海市崇明县科学技术发展基金(CKY2013-27) 卫生部医药卫生科技发展研究中心课题基金(W2011GJ13)
关键词 胃癌 早期肠外联合肠内 预后 Gastric cancer Early PN combined with EN Prognosis
  • 相关文献

参考文献1

二级参考文献19

  • 1杜舟,余震.耐药基因在胃癌化疗中的研究进展[J].浙江临床医学,2006,8(4):439-440. 被引量:4
  • 2顾汉刚,李小琴,李文军,朱海峰,朱小霞.多西紫杉醇联合顺铂、5-氟尿嘧啶治疗晚期胃癌的临床研究[J].江苏大学学报(医学版),2006,16(3):226-228. 被引量:6
  • 3秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 4HER-2研究全国协作组,张瑰红.胃癌中HER-2/neu基因扩增和蛋白表达的多中心研究[J].中华消化杂志,2006,26(10):657-660. 被引量:17
  • 5Chen WQ, Zheng RS, Zhang SW, et al. Report of incidence and mortality from China cancer registries in 2008 [J]. Chin J Cancer Res, 2012, 24(3): 171-180. doi: 10.1007/ s11670-012-0171-2.
  • 6Garcia I, Vizoso F, Martin A, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer[J]. Ann Surg Oncol, 2003, 10(3): 234-241.
  • 7Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in advanced gastric cancer:a systematic review and meta- analysis based on aggregate data [J].J Clin Oneol, 2006, 24(18): 2903-2909.
  • 8Cunningham D, Okines AF, Ashley S. Capecitabine and ox- aliplatin for advanced esophagogastric cancer [J].N Engl J Med, 2010, 362(9): 858-859. doi: 10.1056/NEJMc0911925.
  • 9Ajani JA. Evolving chemotherapy for advanced gastric can- cer [J]. Oneologist, 2005, lO(Suppl 3): 49-58.
  • 10Lordiek F, Kang YK, Chung HC, et al. Capeeitabine and eisplatin with or without eetuximab for patients with previ- ously untreated advanced gastrie cancer (EXPAND): a ran- domised, open-label phase 3 trial [J].Lancet Oneol, 2013, 14(6): 490-499. doi: 10.1016/S1470-2045(13)70102-5.

共引文献5

同被引文献42

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部